These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23775012)
21. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis. Wang Y; Wang D; Ren M Tumour Biol; 2014 Jan; 35(1):33-8. PubMed ID: 23873100 [TBL] [Abstract][Full Text] [Related]
22. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis. Ji YN; Wang Q; Xue J Tumour Biol; 2014 Feb; 35(2):1653-9. PubMed ID: 24078450 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis. He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104 [TBL] [Abstract][Full Text] [Related]
24. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263 [TBL] [Abstract][Full Text] [Related]
25. VEGF-C expression is associated with the poor survival in gastric cancer tissue. Cao W; Fan R; Yang W; Wu Y Tumour Biol; 2014 Apr; 35(4):3377-83. PubMed ID: 24307624 [TBL] [Abstract][Full Text] [Related]
26. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001 [TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis. Huang L; Ren F; Tang R; Feng Z; Chen G Technol Cancer Res Treat; 2016 Feb; 15(1):12-9. PubMed ID: 25627202 [TBL] [Abstract][Full Text] [Related]
29. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis. Xu XL; Chen SZ; Chen W; Zheng WH; Xia XH; Yang HJ; Li B; Mao WM Breast Cancer Res Treat; 2013 Jun; 139(2):329-39. PubMed ID: 23670132 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of cyclin E expression in patients with ovarian cancer: a Meta-analysis. Wang X; Qi X; Ming X; Wang L; Wang Y; Zhao X J BUON; 2017; 22(1):64-71. PubMed ID: 28365937 [TBL] [Abstract][Full Text] [Related]
31. The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data. Bozovic-Spasojevic I; Zardavas D; Brohée S; Ameye L; Fumagalli D; Ades F; de Azambuja E; Bareche Y; Piccart M; Paesmans M; Sotiriou C Clin Cancer Res; 2017 Jun; 23(11):2702-2712. PubMed ID: 28151718 [No Abstract] [Full Text] [Related]
32. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of FoxM1 expression in non-small cell lung cancer. Sun Q; Dong M; Chen Y; Zhang J; Qiao J; Guo X J Thorac Dis; 2016 Jun; 8(6):1269-73. PubMed ID: 27293846 [TBL] [Abstract][Full Text] [Related]
34. Meta-analysis for cyclin E in lung cancer survival. Huang LN; Wang DS; Chen YQ; Li W; Hu FD; Gong BL; Zhao CL; Jia W Clin Chim Acta; 2012 Apr; 413(7-8):663-8. PubMed ID: 22244930 [TBL] [Abstract][Full Text] [Related]
35. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern. Berglund P; Stighall M; Jirström K; Rydén L; Fernö M; Nordenskjöld B; Landberg G J Clin Pathol; 2008 Feb; 61(2):184-91. PubMed ID: 17483245 [TBL] [Abstract][Full Text] [Related]
36. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Lemée F; Bergoglio V; Fernandez-Vidal A; Machado-Silva A; Pillaire MJ; Bieth A; Gentil C; Baker L; Martin AL; Leduc C; Lam E; Magdeleine E; Filleron T; Oumouhou N; Kaina B; Seki M; Grimal F; Lacroix-Triki M; Thompson A; Roché H; Bourdon JC; Wood RD; Hoffmann JS; Cazaux C Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13390-5. PubMed ID: 20624954 [TBL] [Abstract][Full Text] [Related]
37. Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion. Berglund P; Landberg G Cell Cycle; 2006 Mar; 5(6):606-9. PubMed ID: 16582601 [TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of cyclin E in low-risk node negative breast cancer. Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847 [TBL] [Abstract][Full Text] [Related]
39. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer. Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Zhan P; Ji YN Hepatobiliary Surg Nutr; 2014 Feb; 3(1):11-7. PubMed ID: 24696834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]